Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Indian Cancer Genome Atlas launches the country’s first comprehensive cancer multi-omics data portal

by AIP Online Bureau | Sep 21, 2024 | Data, Eco/Invest/Demography, Health

The ICGA cancer multi-omics portal is the first in India to offer data that includes DNA, RNA, and protein profiles of breast cancer patients, integrated with clinical outcomes New Delhi: The Indian Cancer Genome Atlas (ICGA) has launched India’s first...

Union Budget 2024: Govt to exempt three more cancer drugs from customs duty

by AIP Online Bureau | Jul 23, 2024 | Health, Indian News, Policy

The three drugs are Trastuzumab deruxtecan, Osimertinib and Durvalumab. The reduction in customs duty may help reduce the financial burden on those battling the deadly disease New Delhi: In a big relief to cancer patients, Union Finance Minister Nirmala Sitharaman,...

Your favourite pani puri may increase risk of cancer, asthma & more

by AIP Online Bureau | Jul 3, 2024 | Data, Health, Regulation

“Use of an excess amount of artificial food colours and flavouring agents to make the dish look more appealing and increase palatability carries various health risks, especially in those who frequently indulge in outside food,” Edwina Raj, Head of Services –...

J&J talc users want cancer checks for women even if it cost billions

by AIP Online Bureau | Jun 18, 2024 | Eco/Invest/Demography, Health, International News

The suit is the latest salvo in the ongoing legal battle between J&J and former talc users, who allege the world’s largest maker of health-care products hid the cancer risks of its iconic baby powder for almost half a century. J&J is seeking the backing from...

Sanofi to pay over $100 million to settle about 4,000 Zantac cancer lawsuits

by AIP Online Bureau | Apr 23, 2024 | Health, International News, Regulation

But the relatively modest settlement should please Sanofi investors, who’ve worried in the past about the financial fallout of thousands of US lawsuits targeting Zantac makers such as Sanofi and GSK Plc, which originally developed the product Zantac was recalled in...
« Older Entries
Next Entries »

Recent Posts

  • (no title)
  • (no title)
  • IRDAI drops plans to change existing bancassurance rules for curbing mis-selling by insurers
  • Indian companies paid Rs4 crore on average for cyber attack demands: Report
  • SBI General announces awareness campaign for Kharif 2025

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy